Mukka Proteins last traded at ₹26.30 (2026-10-13). Over the past month the stock moved -13.5%, three months the stock moved +14.6%, year the stock moved -5.9%. Its closing range over 52 weeks is ₹19.84 – ₹32.15, with the latest close 18.2% below the high.
Closing prices up to 2026-10-13.
Incorporated in 2003, Mukka Proteins Ltd is a manufacturer and exporter of Fish Meal and Fish oil[1]
Business Overview:[1] MPL manufactures Fish Protein products and supplies fish meal, fish oil and fish soluble paste which is an essential ingredient in manufacturing of aqua feed (for fish and shrimp), poultry feed (for broiler and layer) and pet food (dog and cat food). Further, fish oil also finds application in pharmaceutical products (Omega-3 pills and related products derived from fish oil), soap manufacturing, leather tanneries and paint industries
In the latest quarter (Jun 2026), Mukka Proteins reported sales of ₹490.00 crore (+186.5%) and net profit of ₹19.00 crore (+850.0%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 490.00 | 47.00 | 10.00 | 19.00 | 0.63 |
| Mar 2026 | 381.00 | 34.00 | 9.00 | 21.00 | 0.69 |
| Dec 2025 | 654.00 | 45.00 | 7.00 | 27.00 | 0.79 |
| Sep 2025 | 245.00 | 20.00 | 8.00 | 7.00 | 0.20 |
| Jun 2025 | 171.00 | 14.00 | 8.00 | 2.00 | 0.05 |
| Mar 2025 | 382.00 | 29.00 | 8.00 | 14.00 | 0.45 |
| Dec 2024 | 303.00 | 41.00 | 14.00 | 27.00 | 0.88 |
| Sep 2024 | 149.00 | 10.00 | 6.00 | 1.00 | 0.07 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -55.1% | -41.4% | +48.6% | -0.6% | +64.4% | +115.8% | -0.3% | +186.5% |
| Operating profit growth | -73.7% | +115.8% | -9.4% | +0.0% | +100.0% | +9.8% | +17.2% | +235.7% |
| Net profit growth | -96.6% | +125.0% | -51.7% | -60.0% | +600.0% | +0.0% | +50.0% | +850.0% |
| EPS growth | -94.5% | +83.3% | -50.5% | -64.3% | +185.7% | -10.2% | +53.3% | +1160.0% |
| OPM % | 6.0% | 14.0% | 8.0% | 8.0% | 8.0% | 7.0% | 9.0% | 10.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Mukka Proteins reported sales of ₹1,449.00 crore (+44.0%) and net profit of ₹57.00 crore (+18.8%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 1,449 | 115.00 | 8.00 | 57.00 | 1.74 |
| Mar 2025 | 1,006 | 95.00 | 9.00 | 48.00 | 1.55 |
| Mar 2024 | 1,380 | 105.00 | 8.00 | 74.00 | 2.34 |
| Mar 2023 | 1,177 | 86.00 | 7.00 | 48.00 | 2.00 |
| Mar 2022 | 770.00 | 48.00 | 6.00 | 26.00 | 1.10 |
| Mar 2021 | 604.00 | 22.00 | 4.00 | 11.00 | – |
| Mar 2020 | 549.00 | 24.00 | 4.00 | 14.00 | – |
| Mar 2019 | 409.00 | 23.00 | 6.00 | 14.00 | – |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales growth | +34.2% | +10.0% | +27.5% | +52.9% | +17.2% | -27.1% | +44.0% |
| Operating profit growth | +4.3% | -8.3% | +118.2% | +79.2% | +22.1% | -9.5% | +21.1% |
| Net profit growth | +0.0% | -21.4% | +136.4% | +84.6% | +54.2% | -35.1% | +18.8% |
| EPS growth | – | – | – | +81.8% | +17.0% | -33.8% | +12.3% |
| OPM % | 4.0% | 4.0% | 6.0% | 7.0% | 8.0% | 9.0% | 8.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Mukka Proteins.
Get Free AI Stock Analysis FREE →Mukka Proteins consolidated net profit rises 1142.76% in the June 2026 quarter - Business Standard
Mukka Proteins approves ₹47 crore warrant issue to fund growth - scanx.trade
Mukka Proteins consolidated net profit rises 51.73% in the March 2026 quarter - Business Standard
Mukka Proteins Limited Publishes Newspaper Advertisement for Audited FY26 Financial Results Under SEBI Regulation 47 - scanx.trade
Mukka Proteins Limited Publishes Newspaper Advertisement for Audited FY26 Financial Results Under SEBI Regulation 47 - scanx.trade
Mukka Proteins Limited Publishes Newspaper Advertisement for Audited FY26 Financial Results Under SEBI Regulation 47 - scanx.trade
Mukka Proteins consolidated net profit rises 51.73% in the March 2026 quarter - Business Standard
Mukka Proteins gets nod to make investment in United Gulf Fishery Products LLC
Mukka Proteins zooms on getting nod to make investment in United Gulf Fishery Products LLC
Mukka Proteins shares were last quoted at ₹26.30 (+0.1% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Mukka Proteins has a price-to-earnings (P/E) ratio of 11.95 and a price-to-book (P/B) ratio of 1.59. The industry P/E is 21.13.
The 52-week high of Mukka Proteins is ₹33.24 and the 52-week low is ₹18.32.
The market capitalisation of Mukka Proteins is about ₹824.70 crore.
In the latest quarter (Jun 2026), Mukka Proteins reported sales of ₹490.00 crore (+186.5%) and net profit of ₹19.00 crore (+850.0%), compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Mukka Proteins has a 3-year ROE of 15.00%, 3-year profit growth of 6.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 73.33% of Mukka Proteins.
Mukka Proteins belongs to the Consumer Food sector.